![Sri Radhakrishnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 430 611 $ al 30/06/2026
Sri Radhakrishnan is currently Chief Science & Technology Officer at Pulmonx Corp., a position held since 2008.
Education history includes graduate studies at The University of Alabama and undergraduate studies at the University of Mumbai.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PULMONX CORP. 0,78 % | 01/06/2026 | 331.239 ( 0,78 % ) | 430 611 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PULMONX CORPORATION | Director Técnico/Científico/I+D | 01/02/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Pulmonx Corp.
 Pulmonx Corp. Medical SpecialtiesHealth Technology Develops and manufactures zephyr endobronchial valves for the treatment of emphysema | Health Technology |
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
